​Kembara Xtra - Medicine - Roseola

​Kembara Xtra - Medicine - Roseola 
Infection that is pervasive in childhood and early life.
Human herpesvirus 6 (HHV-6) is responsible for the majority of instances and may be linked to other illnesses, such as encephalitis.


Acute infection in newborns or young children causes a high fever, which is followed by a skin eruption when the fever subsides. Transmission occurs when saliva or respiratory droplets come into touch with the patient. Skin/exocrine, metabolic, gastrointestinal, respiratory, and neurologic system(s) involved. Incubation period of 9 to 10 days. Synonym(s): pseudorubella; sixth disease; 3-day fever


Epidemiology: Peak age of infection is 6 to 9 months, with congenital or prenatal infection being rare. Predominant age group for HHV-6 is infants and young children (under 2 years old).By the age of two, 95% of children had contracted HHV-6.
- HHV-7 - Later childhood - Mean age of infection 26 months - More than 90% of the population has HHV-7 by 10 years - Predominant sex: male = female - No seasonal variation
Common—represents 20% of ED visits for febrile illness in children aged 6 to 8 months.

 Prevalence
Between 9 and 21 months is when prevalence peaks.
By three years, almost all people had HHV-6. Roseola affects 20% of people with primary HHV-6.


Pathophysiology and Etiology 
HHV-6 and HHV-7 HHV-6B is more common than HHV-6A in the majority of cases (60–74%) - HHV-6A detected in young African youngsters
- All nucleated cells have CD46 receptors, which HHV-6 attaches to.
Primary infection usually caused by saliva or respiratory droplets .1% of instances involve congenital infection or vertical transfer.
- Transmission transplacentally
- Chromosomal integration (unknown clinical relevance)
.
After primary infection, a lifelong latent or persistent asymptomatic infection develops.
- 80–90% of the population sporadically excretes HHV-6 and HHV-7 in saliva.
- Patients are viremic from two days prior to the commencement of a fever to the onset of defervescence and rash.
- The CSF is also connected to HHV-6 latency.
Genetics
0.2–3.0% of the population has HHV-6 incorporated into their chromosomes. The virus spreads vertically as a result of this. This's clinical relevance is unknown.


Risk factors include being a woman, having elder siblings, being immunocompromised, and having had a bone marrow transplant (BMT), among other solid organ transplants. In the first week following a transplant, HHV-6 reactivation is possible.
30-45% of BMT develop HHV-6 viremia within the first several weeks of transplantation.
Most often asymptomatic HHV-6 reactivation/reinfection rates as high as 82% in solid organ transplant



The child may be fussy throughout this prodrome. Diagnosis: 3 to 5 days sudden fever 102.2-104.0°F (39-40°C) not linked with a rash.
A rash that first appears on the trunk then spreads centrifugally to the neck, probably the face, and possibly the extremities is connected with a sudden drop in temperature. Mild upper respiratory symptoms, including diarrhea.In 13% of cases of rhinorrhea, febrile seizures happen.


Clinical evaluation 

Exanthem subitum, Rash - Rose-pink papules and/or macules that blanch - show on the trunk first, then spread outward - May show up to 3 days after the fever goes away - Fades in 2 days - Affects 20% of patients in the USUlcers on the soft palate and uvula (Nagayama spots) Mild tympanic membrane, throat, and/or conjunctival irritation Cervical lymphadenopathy Periorbital edema

Differential diagnosis: Rubella, scarlet fever, drug eruption, measles, enterovirus infection, adenovirus infection, Epstein-Barr virus, and parvovirus B19. 

Laboratory Results 

Tests frequently cannot distinguish between a latent or active disease, making the diagnosis primarily clinical and not requiring laboratory or radiologic evaluation.
Only in extreme cases, an exact diagnosis is required; in cases of uncertainty, a more dangerous condition must be ruled out before considering antiviral therapy.

Initial examinations (lab, imaging): PCR detection of HHV-6 and HHV-7 in serum, whole blood, CSF, or saliva if indicated.
- Increasing in popularity
- Not necessary in people who are not immunocompromised
 IgM immunofluorescence for HHV-6HHV-6 IgG immunofluorescence - Check at diagnosis and then again two weeks later. Diagnostic for acute infection - Spike noticed in the first week of sickness.
- To demonstrate primary infection, use with IgM.
- Primary infection is suggested by a negative initial test and an increase on follow-up.
Other laboratory results include decreased total leukocytes, lymphocytes, and neutrophils, elevated transaminases, and thrombocytopenia. Viral culture is rarely performed, has no clinical utility, and takes a lot of time.


Other/Diagnostic Procedures

Chest x-ray (CXR): if a kid exhibits respiratory symptoms; urine culture: to rule out UTI as the cause of fever


Management 
Treatment is not required, and there are no aftereffects 


General Actions 
Hydration and symptom alleviation, especially antipyretics

First Line of Medicine
No specific first-line therapy, other than supportive measures, is available in immunocompetent hosts. Antivirals are not advised for immunocompetent patients.
There is no approved antiviral therapy for immunocompromised people.
HHV-6B susceptible: ganciclovir and foscarnet; HHV-6A and HHV-7 are more resistant to ganciclovir. Second-line IV ganciclovir, cidofovir, and foscarnet tested in vitro investigations in stem cell transplant patients.
Antivirals have been recommended in specific cases of encephalitis (linked to reactivation of HHV-6)
Ganciclovir prophylaxis is effective in avoiding HHV-6 reactivation in bone marrow and stem cell transplant recipients who are receiving immunosuppression.


Patient Follow-Up Monitoring
In the febrile prodrome, keep an eye out for dehydration.
None once the normal rash develops and the fever goes away.
The average ailment lasts six days.
If febrile seizures happen, they will stop after the fever goes down and are unlikely to happen again.
 Reactivation of symptoms in immunocompromised

Encourage water in the diet.


Parental assurance that this is typically a benign, self-limited condition through patient educationNo particular time frame for excluding affected children from outside-of-home care is advised.
Prior to the beginning of fever and up until the period of defervescence and rash, the patient is viremic.


Reactivation in immunocompromised people is prevalent. Course: acute, full recovery without sequelae.


Complications 

1/3 of all primary seizures in children under the age of two are caused by febrile seizures, which affect 13% of kids with roseola.  Reactivation can happen in transplant patients, those with HIV infection, and other immunocompromised people. Medication hypersensitivity syndromes (drug reaction with eosinophilia and systemic symptoms).
Meningoencephalitis affects immunocompetent and immunosuppressed patients, and there is little correlation between it and multiple sclerosis. Pityriasis rosea may be related to progressive multifocal leukoencephalopathy.

---